Revance to Participate in Upcoming Investor Conferences
Chief Financial Officer
Goldman Sachs 45th Annual Global Healthcare Conference
President and Chief Executive Officer
Interested parties can access the live audio webcasts for the conferences from the Investor Relations section of the company's website at www.revance.com. The webcast replays will be available after the conclusion of the live presentations for approximately 90 days.
About Revance
Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences. Revance’s portfolio includes DAXXIFY® (DaxibotulinumtoxinA-lanm) for injection and the RHA® Collection of dermal fillers in the
Revance’s global headquarters and experience center is located in
“Revance”, the Revance logo, and DAXXIFY are registered trademarks of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528756057/en/
Investors
laurence@newstreetir.com
Media
Revance@evolvemkd.com
Source: